As of Feb 24
| +0.10 / +2.39%|
The 1 analysts offering 12-month price forecasts for Sunesis Pharmaceuticals Inc have a median target of 5.00, with a high estimate of 5.00 and a low estimate of 5.00. The median estimate represents a +16.55% increase from the last price of 4.29.
The current consensus among 1 polled investment analysts is to Buy stock in Sunesis Pharmaceuticals Inc. This rating has held steady since February, when it was unchanged from a Move your mouse over past
months for detail
Move your mouse over a quarter or year to see how estimates have changed over time.